Mirabella Financial Services LLP Abbott Laboratories Transaction History

Mirabella Financial Services LLP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$109.52 - $120.96 $8.38 Million - $9.26 Million	-76,525 Reduced 78.51%	20,946 $2.38 Million
Q4 2023 Feb 14, 2024	BUY	$90.19 - $110.4 $8.79 Million - $10.8 Million	97,471 New	97,471 $10.7 Million
Q2 2022 Aug 12, 2022	BUY	$102.07 - $123.37 $148,818 - $179,873	1,458 Added 26.01%	7,064 $767,000
Q1 2022 May 17, 2022	BUY	$114.02 - $139.04 $639,196 - $779,458	5,606 New	5,606 $664,000
Q4 2021 Feb 14, 2022	SELL	$115.53 - $141.46 $7.87 Million - $9.64 Million	-68,114 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$116.66 - $129.06 $7.56 Million - $8.37 Million	64,836 Added 1977.91%	68,114 $8.05 Million
Q2 2021 Aug 13, 2021	BUY	$105.79 - $124.53 $346,779 - $408,209	3,278 New	3,278 $380,000

3,186

1.3B

8.74M

8.08M

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $206B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

Get notified when there are updates to the investment portfolio of Mirabella Financial Services LLP, based on Form 13F filings with the SEC.

Stay updated on Mirabella Financial Services LLP with notifications on news.